The DOI matches its Crossref record; the references it cites are not checked yet.
A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures
Open accessAbstract
Non-alcoholic fatty liver disease (NAFLD) is a common, progressive liver disease strongly associated with the metabolic syndrome. It is unclear how progression of NAFLD towards cirrhosis translates into systematic changes in circulating proteins. Here, we provide a detailed proteo-transcriptomic map of steatohepatitis and fibrosis during progressive NAFLD. In this multicentre proteomic study, we characterize 4,730 circulating proteins in 306 patients with histologically characterized NAFLD and integrate this with transcriptomic analysis in paired liver tissue. We identify circulating proteomic signatures for active steatohepatitis and advanced fibrosis, and correlate these with hepatic transcriptomics to develop a proteo-transcriptomic signature of 31 markers. Deconvolution of this signature by single-cell RNA sequencing reveals the hepatic cell types likely to contribute to proteomic changes with disease progression. As an exemplar of use as a non-invasive diagnostic, logistic regression establishes a composite model comprising four proteins (ADAMTSL2, AKR1B10, CFHR4 and TREM2), body mass index and type 2 diabetes mellitus status, to identify at-risk steatohepatitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Further correlation of circulating proteomics with liver transcriptomics has generated a proteo-transcriptomic signature that outperforms current non-invasive methods in predicting patients with progressive MASLD (124).”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [124]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 20 · Cited by 178
Metadata
- Authors
- Govaere, O., Hasoon, M., Alexander, L., Cockell, S., Tiniakos, D., Ekstedt, M., Schattenberg, J. M., Boursier, J., Bugianesi, E., Ratziu, V., LITMUS Investigators, Daly, A. K., & Anstee, Q. M.
- Affiliations
- Universitair Ziekenhuis Leuven (BE)
- Newcastle University (GB)
- SomaLogic (United States) (US)
- National and Kapodistrian University of Athens (GR)
- Linköping University (SE)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- University of Turin (IT)
- Sorbonne Université (FR)
- NIHR Newcastle Biomedical Research Centre (GB)
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- Corresponding author
- Anstee, Quentin M.
- ORCID
- Venue
- Nature Metabolism
- Published
- 2023-04-10
- Volume
- 5
- Issue
- 4
- Pages
- 572-578
- ISSN
- 2522-5812 (ISSN-L)
- PMC
- PMC10132975
- OpenAlex
- W4363676289
- Cited by
- 178
- References
- 20
- Citations by year
- 2026: 58 · 2025: 60 · 2024: 47 · 2023: 13
- FWCI
- 35.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Metabolism (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- Lirias (submittedVersion, other-oa)
- DiVA (Linkoping University) (submittedVersion, other-oa)
- HAL (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- EC | Horizon 2020 Framework Programme (634413)
- Innovative Medicines Initiative (777377)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- non-alcoholic fatty liver disease, steatohepatitis, liver fibrosis, circulating proteins, non-invasive diagnosis, ADAMTSL2, AKR1B10, TREM2, disease progression, metabolic syndrome, type 2 diabetes, body mass index
- MeSH terms
- ADAMTS Proteins, Aldo-Keto Reductases, Single-Cell Gene Expression Analysis, Adult, Aged, Apolipoproteins, Diabetes Mellitus, Type 2, Fatty Liver, Female, Humans, Immunohistochemistry, Liver Cirrhosis, Male, Membrane Glycoproteins, Middle Aged, Receptors, Immunologic, Registries, Cohort Studies, Body Mass Index, Logistic Models, Disease Progression, Gene Expression Profiling, Proteomics, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures. https://app.cochat.ai/papers/10.1038/s42255-023-00775-1
- The paper
- Govaere, O., Hasoon, M., Alexander, L., Cockell, S., Tiniakos, D., Ekstedt, M., Schattenberg, J. M., Boursier, J., Bugianesi, E., Ratziu, V., LITMUS Investigators, Daly, A. K., & Anstee, Q. M. (2023). A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures. Nature Metabolism. https://doi.org/10.1038/s42255-023-00775-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.